Arthritis drugs may help sickest Covid-19 patients: Treating critically ill COVID-19 patients with drugs typically used for arthritis may significantly improve survival, a landmark study has found. The findings, which have not yet been peer-reviewed, come from the REMAP-CAP trial, which evaluates the effect of treatments on a combination of survival and length of time […]
Read More… from Arthritis drugs may help sickest Covid-19 patients
The true cost of chemotherapy: Chemotherapy for breast cancer costs the UK economy more than £248 million annually, including ‘out-of-pocket’ personal costs of more than £1,000 per patient – according to new research from the University of East Anglia. A new study published today is the first to investigate the total non-healthcare cost of chemotherapy […]
Beta-blockers are used to prevent internal bleeding in patients with liver cirrhosis and portal hypertension. Researchers from MedUni Vienna have now shown that Beta-blockers also have beneficial effects on systemic inflammation and this translates into improved clinical outcomes. Approximately 170,000 people die every year in Europe from the direct consequences of advanced chronic liver disease […]
Read More… from Beta-blockers display anti-inflammatory effects in advanced liver disease
Technology innovation award from the Safety Pharmacology Society for Coventry University Researchers Researchers from the Centre for Sport, Exercise and Life Sciences (CSELS) and Coventry University spin-out company InoCardia have been presented with two prestigious awards from the Safety Pharmacology Society (SPS). PhD student Sophie Fletcher, Professor Helen Maddock , Professor Rob James , Dr Rob Wallis, and Dr Mayel […]
Read More… from Coventry Uni claims Technology Innovation awards
Comment from Royal Pharmaceutical Society: safety of staff and patients paramount to the COVID-19 vaccine programme: Following the news that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for rollout in the UK from next week, we are calling for the safety of pharmacy teams and their patients to […]
Read More… from Safety paramount to COVID-19 vaccine programme
Fiji’s national vaccine program against pneumonia, a serious lung condition, and rotavirus, a common disease which causes severe diarrhoea and vomiting, has reduced illness and death, new research shows. The University of Melbourne-led research team, which worked with the Fiji Ministry of Health and Medical Services, says the results underline the importance of vaccines and […]
Read More… from Fiji’s vaccine program reduces childhood death and illness: study
A drug that acts via the natural ‘kisspeptin’ hormone system in the body has the potential to treat reproductive health problems in women, according to a new study. Twenty-four women were injected with a drug called MVT-602 which targets the kisspeptin system to stimulate reproductive hormones that affect fertility, sexual development and menstruation. The naturally occurring […]
Read More… from New drug improves fertility in women with reproductive health problems
Critically ill patients with COVID-19 treated with an arthritis drug that reduces inflammation are significantly more likely to have improved outcomes, an international study has found. The early findings, which are yet to be published, come from the REMAP-CAP trial, led by Imperial College London and the Intensive Care National Audit & Research Centre (ICNARC) […]
Read More… from Arthritis drug effective in treating sickest COVID-19 patients
World-first skin cancer treatment aims to help transplant patients: A new medication which can be applied to the skin could help prevent organ transplant recipients from developing harmful skin cancers. The world-first treatment being developed at The University of Queensland is the only drug of its type that could prevent the incidence of skin cancers […]
Read More… from Skin cancer treatment to help transplant patients
The NHS could improve patients’ access to new cancer treatments by paying different prices for drugs depending on the disease they are used to treat, concludes a group of experts from across academia and industry. The consensus panel, representing 16 leading academic institutions, charities, stakeholder groups and pharmaceutical companies, also called for the Government to […]